• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与迁移小体相关的整合素α5用于预测肝细胞癌的预后、免疫浸润和药物敏感性

Migrasome-related ITGA5 for predicting prognosis, immune infiltration and drug sensitivity of hepatocellular carcinoma.

作者信息

Chen Wanjin, Liu Kailin, Wang Zhiling, Zhang Hui, Tan Ming, Liu Yuting, Gao Tingting, Su Xiameng, Gu Leirong, Chen Xinyan, Cheng Shengtao

机构信息

Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.

Key Laboratory of Molecular Biology of Infectious Diseases Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, 400016, China.

出版信息

Apoptosis. 2025 Mar 27. doi: 10.1007/s10495-025-02103-2.

DOI:10.1007/s10495-025-02103-2
PMID:40146484
Abstract

To clarify the biological functions and prognostic significance of migrasome-related integrin subunit alpha 5 (ITGA5) in hepatocellular carcinoma (HCC). We used The Cancer Genome Atlas datasets and RNA-seq data from nine sets of paired HCC and adjacent normal tissues to identify key migrasome-related genes through a comprehensive analysis and weighted correlation network analysis. We then confirmed their roles in HCC through analyses of gene mutations, methylation, and immune cell infiltration, as well as molecular docking, molecular dynamics, and cell experiments. A comprehensive analysis of migrasome-related genes showed that ITGA5 was a critical gene related to HCC, and it is highly expressed in HCC tissues, which is related to poor prognosis. Further enrichment analysis revealed that ITGA5 is involved in many pathways related to tumor occurrence and metastasis, such as the PI3K-AKT pathway. In addition, ITGA5 was found to be expressed in multiple types of immune cells and was closely associated with immune infiltration. Drug sensitivity, molecular docking, and molecular dynamics analyses indicated that ITGA5 may enhance the sensitivity of HCC to drug TGX221. Finally, cell phenotype experiments confirmed that ITGA5 knockdown suppressed the proliferation, migration, and invasion of HCC cells, and while overexpression exacerbated malignant phenotypes. Our analyses showed that ITGA5 is a key migrasome-related gene involved in the proliferation and metastasis of HCC that has promise as a therapeutic target and candidate prognostic indicator.

摘要

为了阐明迁移体相关整合素亚基α5(ITGA5)在肝细胞癌(HCC)中的生物学功能及预后意义。我们使用了癌症基因组图谱数据集以及来自9组配对的HCC组织和癌旁正常组织的RNA测序数据,通过综合分析和加权相关网络分析来鉴定关键的迁移体相关基因。然后,我们通过基因突变、甲基化、免疫细胞浸润分析以及分子对接、分子动力学和细胞实验来证实它们在HCC中的作用。对迁移体相关基因的综合分析表明,ITGA5是与HCC相关的关键基因,在HCC组织中高表达,这与预后不良相关。进一步的富集分析显示,ITGA5参与许多与肿瘤发生和转移相关的途径,如PI3K-AKT途径。此外,发现ITGA5在多种免疫细胞中表达,并与免疫浸润密切相关。药物敏感性、分子对接和分子动力学分析表明,ITGA5可能增强HCC对药物TGX221的敏感性。最后,细胞表型实验证实,ITGA5基因敲低抑制了HCC细胞的增殖、迁移和侵袭,而过表达则加剧了恶性表型。我们的分析表明,ITGA5是参与HCC增殖和转移的关键迁移体相关基因,有望成为治疗靶点和候选预后指标。

相似文献

1
Migrasome-related ITGA5 for predicting prognosis, immune infiltration and drug sensitivity of hepatocellular carcinoma.与迁移小体相关的整合素α5用于预测肝细胞癌的预后、免疫浸润和药物敏感性
Apoptosis. 2025 Mar 27. doi: 10.1007/s10495-025-02103-2.
2
Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy.白藜芦醇通过下调 AKR1C3 抑制肝癌进展:以 HSA 纳米材料为载体靶向 HCC 以增强治疗效果。
Apoptosis. 2024 Oct;29(9-10):1429-1453. doi: 10.1007/s10495-024-01995-w. Epub 2024 Jul 18.
3
hsa_circ_0000518 stimulates the malignant progression of hepatocellular carcinoma via regulating ITGA5 to activate the Warburg effect.hsa_circ_0000518 通过调控 ITGA5 激活瓦博格效应促进肝癌的恶性进展。
Cell Signal. 2024 Aug;120:111243. doi: 10.1016/j.cellsig.2024.111243. Epub 2024 Jun 1.
4
A novel mitochondrial unfolded protein response-related risk signature to predict prognosis, immunotherapy and sorafenib sensitivity in hepatocellular carcinoma.一种新型的线粒体未折叠蛋白反应相关风险特征,可预测肝细胞癌的预后、免疫治疗和索拉非尼敏感性。
Apoptosis. 2024 Jun;29(5-6):768-784. doi: 10.1007/s10495-024-01945-6. Epub 2024 Mar 17.
5
A liver-specific lncRNA, FAM99B, suppresses hepatocellular carcinoma progression through inhibition of cell proliferation, migration, and invasion.一种肝脏特异性长链非编码 RNA(lncRNA),FAM99B,通过抑制肝癌细胞的增殖、迁移和侵袭来抑制肝癌的进展。
J Cancer Res Clin Oncol. 2019 Aug;145(8):2027-2038. doi: 10.1007/s00432-019-02954-8. Epub 2019 Jun 26.
6
DDX42 Enhances Hepatocellular Carcinoma Cell Proliferation, Radiation and Sorafenib Resistance via Regulating GRB2 RNA Maturation and Activating PI3K/AKT Pathway.DDX42通过调节GRB2 RNA成熟和激活PI3K/AKT通路增强肝癌细胞增殖、辐射抗性和索拉非尼抗性。
J Cell Mol Med. 2025 Aug;29(16):e70793. doi: 10.1111/jcmm.70793.
7
Bioinformatics analysis and experimental studies reveal KPNA2 as a novel biomarker of hepatocellular carcinoma progression and telomere maintenance.生物信息学分析和实验研究表明,核转运蛋白α2(KPNA2)是肝细胞癌进展和端粒维持的一种新型生物标志物。
Eur J Med Res. 2025 Jul 16;30(1):628. doi: 10.1186/s40001-025-02866-z.
8
Nuclear factor IA-mediated transcriptional regulation of crystallin αB inhibits hepatocellular carcinoma progression.核因子IA介导的晶状体蛋白αB转录调控抑制肝细胞癌进展。
Mol Clin Oncol. 2025 Jun 20;23(2):72. doi: 10.3892/mco.2025.2867. eCollection 2025 Aug.
9
CEP55: Implications for Immunotherapy and Survival in Hepatocellular Carcinoma.CEP55:对肝细胞癌免疫治疗和生存的影响
Comb Chem High Throughput Screen. 2024 Jun 6. doi: 10.2174/0113862073298525240522104104.
10
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.肿瘤相关中性粒细胞招募巨噬细胞和 T 调节细胞促进肝细胞癌进展和索拉非尼耐药。
Gastroenterology. 2016 Jun;150(7):1646-1658.e17. doi: 10.1053/j.gastro.2016.02.040. Epub 2016 Feb 26.

引用本文的文献

1
ITGA5 promotes cervical cancer progression by regulating IMP3 recruitment of HK2 mRNA.整合素α5通过调控HK2 mRNA的IMP3募集促进宫颈癌进展。
Am J Transl Res. 2025 Apr 15;17(4):3031-3049. doi: 10.62347/GGVE9638. eCollection 2025.

本文引用的文献

1
Multi-omics analysis identifies BCAT2 as a potential pan-cancer biomarker for tumor progression and immune microenvironment modulation.多组学分析鉴定 BCAT2 为一种潜在的泛癌肿瘤进展和免疫微环境调节的生物标志物。
Sci Rep. 2024 Oct 8;14(1):23371. doi: 10.1038/s41598-024-74441-1.
2
Prognosis of colorectal cancer, prognostic index of immunogenic cell death associated genes in response to immunotherapy, and potential therapeutic effects of ferroptosis inducers.结直肠癌的预后、免疫治疗反应相关免疫原性细胞死亡的预后指标,以及铁死亡诱导剂的潜在治疗效果。
Front Immunol. 2024 Sep 20;15:1458270. doi: 10.3389/fimmu.2024.1458270. eCollection 2024.
3
CDC25B Is a Prognostic Biomarker Associated With Immune Infiltration and Drug Sensitivity in Hepatocellular Carcinoma.
CDC25B是一种与肝细胞癌免疫浸润和药物敏感性相关的预后生物标志物。
Int J Genomics. 2024 Sep 28;2024:8922878. doi: 10.1155/2024/8922878. eCollection 2024.
4
Identification of telomere-related lncRNAs and immunological analysis in ovarian cancer.卵巢癌中端粒相关长链非编码RNA的鉴定及免疫分析
Front Immunol. 2024 Sep 17;15:1452946. doi: 10.3389/fimmu.2024.1452946. eCollection 2024.
5
IGFBP2/ITGA5 promotes gefitinib resistance via activating STAT3/CXCL1 axis in non-small cell lung cancer.IGFBP2/ITGA5 通过激活 STAT3/CXCL1 轴促进非小细胞肺癌对吉非替尼的耐药性。
Cell Death Dis. 2024 Jun 25;15(6):447. doi: 10.1038/s41419-024-06843-y.
6
Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform.Sangerbox:一个全面的、用户交互友好的临床生物信息学分析平台。
Imeta. 2022 Jul 8;1(3):e36. doi: 10.1002/imt2.36. eCollection 2022 Sep.
7
Quantification of urinary podocyte-derived migrasomes for the diagnosis of kidney disease.尿足细胞来源迁移小体定量用于肾脏疾病的诊断。
J Extracell Vesicles. 2024 Jun;13(6):e12460. doi: 10.1002/jev2.12460.
8
hsa_circ_0000518 stimulates the malignant progression of hepatocellular carcinoma via regulating ITGA5 to activate the Warburg effect.hsa_circ_0000518 通过调控 ITGA5 激活瓦博格效应促进肝癌的恶性进展。
Cell Signal. 2024 Aug;120:111243. doi: 10.1016/j.cellsig.2024.111243. Epub 2024 Jun 1.
9
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
10
A novel mitochondrial unfolded protein response-related risk signature to predict prognosis, immunotherapy and sorafenib sensitivity in hepatocellular carcinoma.一种新型的线粒体未折叠蛋白反应相关风险特征,可预测肝细胞癌的预后、免疫治疗和索拉非尼敏感性。
Apoptosis. 2024 Jun;29(5-6):768-784. doi: 10.1007/s10495-024-01945-6. Epub 2024 Mar 17.